PH-20 - A novel tumor marker for laryngeal cancer

Citation
Da. Godin et al., PH-20 - A novel tumor marker for laryngeal cancer, ARCH OTOLAR, 126(3), 2000, pp. 402-404
Citations number
8
Categorie Soggetti
Otolaryngology,"da verificare
Journal title
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
ISSN journal
08864470 → ACNP
Volume
126
Issue
3
Year of publication
2000
Pages
402 - 404
Database
ISI
SICI code
0886-4470(200003)126:3<402:P-ANTM>2.0.ZU;2-1
Abstract
Objective: To determine whether levels of PH-20, a hyaluronidase similar to that found in human sperm, are elevated in laryngeal cancer tissue. Design: In this case-control study, reverse transcription polymerase chain reaction was used to measure levels of PH-20 messenger RNA in tissue taken from laryngectomy specimens. Setting: A university medical center. Patients: We compared tissue samples taken from 11 patients with laryngeal cancer, and from 2 metastatic lymph nodes, with samples of normal, healthy laryngeal tissue and prostate cancer tissue (positive control). Main Outcome Measure: PH-20 complementary DNA expression as quantified by d ensitometric analysis. Results: Expression of PH-20 was significantly higher in nonirradiated lary ngeal cancer specimens than in normal laryngeal tissue (P<.01). Metastatic lymph nodes also had higher levels of PH-20 expression than did primary lar yngeal cancer tissue (P =.11) and normal laryngeal tissue (P<.01). Irradiat ed laryngeal cancer specimens had PH-20 levels comparable to normal. Conclusions: We report the first data on PH-20 expression in laryngeal canc er tissue. PH-20 expression is significantly elevated in primary laryngeal cancer tissue and seems to be even higher in metastatic lesions compared wi th normal laryngeal tissue. PH-20 may be a useful tumor marker and prognost ic tool for laryngeal cancer.